Status:
COMPLETED
PMCF Study on the Safety and Performance of CESPACE 3D
Lead Sponsor:
Aesculap AG
Conditions:
Degenerative Instability
Spondylolisthesis
Eligibility:
All Genders
18+ years
Brief Summary
Prospective, pure data collection of all CeSPACE 3D patients in selected centers (not interventional, multicenter)
Eligibility Criteria
Inclusion
- Patient is minimum 18 years old
- Written informed consent for the documentation of clinical and radiological results
- Patient's indication according to IFU
- Patient is not pregnant
Exclusion
- • Patient is not willing or able to participate at the follow-up examination
Key Trial Info
Start Date :
September 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 16 2024
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04477447
Start Date
September 21 2020
End Date
April 16 2024
Last Update
December 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Katholisches Klinikum Koblenz
Koblenz, Germany, 56073
2
Sana Kliniken Sommerfeld
Kremmen, Germany, 16766